Sergey Orlov

5.7k citations
107 papers · 3.9k · 4 hit papers · h-index 22

Impact in

Papers in

Sergey Orlov

101 papers receiving 3.8k citations

Sergey Orlov's Hit Papers

Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase−Positive Non–Small Cell Lung Cancer 2021 · 184 citations
1840+2+4Years since publication2505007501k

Peers

Sergey Orlov
Comparison fields: 5 of 93
  • Pulmonary and Respiratory Medicine 1.6k
  • Oncology 948
  • Cancer Research 290
  • Pathology and Forensic Medicine 186
  • Biomaterials 127
Replace Toru Mukohara with:
Toru Mukohara Japan
Yun Fan China
Yoichi Naito Japan
Roberto Petrioli Italy
John C. Araujo United States
Tadaaki Yamada Japan
Kadoaki Ohashi Japan
Ilhan Celik Germany
Kaoru Tanaka Japan
Oleg A. Gladkov Russia
Sergey Orlov relative to Toru Mukohara Japan Toru Mukohara's profile →
Citations per field
00.5×1.5×2.2×
Toru Mukohara · 1×
Citations per year

Countries citing papers authored by Sergey Orlov

Since Specialization
Citations

This map shows the geographic impact of Sergey Orlov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey Orlov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey Orlov more than expected).

Fields of papers citing papers by Sergey Orlov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergey Orlov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey Orlov. The network helps show where Sergey Orlov may publish in the future.

Co-authors

The 25 scholars most cited alongside Sergey Orlov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sergey Orlov Line = papers co-authored together Sergey Orlov links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
Hit paper breakdown →
20191134
2
Capmatinib in MET Exon 14–Mutated or MET -Amplified Non–Small-Cell Lung Cancer
Hit paper breakdown →
2020743
3
Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study
Hit paper breakdown →
2020354
4
Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase−Positive Non–Small Cell Lung Cancer
Hit paper breakdown →
2021184
5 2003175
6 2008164
7 201889
8 200967
9 201966
10 199360
11 201154
12 201244
13 201242
14 202442
15 202339
16 201936
17 201035
18 201931
19 201830
20 202325

About Sergey Orlov

Sergey Orlov is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Molecular Biology and Immunology, having authored 107 papers that have together received 3.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (45 papers), Cholesterol and Lipid Metabolism (25 papers), Cancer Immunotherapy and Biomarkers (7 papers), RNA Interference and Gene Delivery (7 papers), Genomics and Chromatin Dynamics (7 papers), Peroxisome Proliferator-Activated Receptors (6 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.6k citations), Oncology (948 citations), Cancer Research (290 citations), Pathology and Forensic Medicine (186 citations) and Biomaterials (127 citations). Sergey Orlov has collaborated with scholars based in Russia, United States and South Korea. Frequent co-authors include Ella B. Dizhe, Perevozchikov Ap, Vladimir S. Shavva, Denis A. Mogilenko, Sergey V. Burov, Wu‐Chou Su, James Chih‐Hsin Yang, Lecia Van Dam Sequist, Byoung Chul Cho and Geoffrey R. Oxnard. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Journal of Biological Chemistry, The Lancet Oncology and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact